Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Elevated costs impact the half

Aust Securities Exchange
3:27pm
February 16, 2024
Despite revenue growth of 2.4% on pcp to ~A$512m, ASX’s 1H24 result was a miss versus market consensus at NPAT (~A$231m, -8% on pcp and ~6% under consensus) on higher total costs than expected (~A$221m, +27% on pcp). We alter our FY24F-FY26F EPS by ~-2-+2% on higher operating expenses near term with an improved margin profile (cost rationalisation) medium-term. Our price target increases to A$62.70 (from A$60.20). Trading on ~26.5x MorgE FY24F PE, slightly above its 10-year average, we still see the elevated expense profile as weighing on the stock near-term. Hold maintained.

1H24: portfolio re-mixing

HomeCo Daily Needs REIT
3:27pm
February 16, 2024
Portfolio fundamentals remain solid and properties continue to re-weight towards higher growth Daily Needs assets vs Large Format Retail. One acquisition and four divestments to settle in 2H24. LFL income grew 4% which is in line with guidance and the active development pipeline remains on track to complete in 2H24 which will assist in valuation uplifts. Planning on new developments valued at +$530m is underway. NTA $1.44. FY24 guidance reaffirmed comprising FFO of 8.6c and DPS of 8.3c. We retain an Add rating with a price target of $1.37.

Quality rising

GQG Partners
3:27pm
February 16, 2024
GQG reported a strong and in-line FY23 result: mgmt fees +16.8%; operating profit +15.7%; NPAT +18.7%. 2H23 earnings were up 19.7% half on half. Investment performance has been solid/strong across all strategies. This supports flows, which have commenced strongly (US$2.9bn CY to-date vs US$2.2bn pcp). Recent FUM growth provides near-term earnings growth visibility. Starting FUM is +18% on avg FY23; current FUM ~30% above. GQG still has meaningful growth based on the current fund offerings; with the longer-term requiring effective management of the eventual CIO transition and adding new growth avenues to the business. We view the recent re-rate as warranted and valuation still attractive (~11.5x FY24 PE). Add maintained.

The COBRA strikes

Clarity Pharmaceuticals
3:27pm
February 16, 2024
CU6 has released initial findings from its Phase 1/2 diagnostic trial in detection prostate cancer (PC) lesions in patients with biochemical recurrence (BCR). The results showed the treatment was broadly safe with only one treatment-related adverse event which resolved, and detected significantly more potential lesions than standard of care imaging. The results have given CU6 confidence to push for a Phase 3 trial, although likely requiring a change in design needed to more accurately validate the volume of positive lesions detected over standard of care.

US$5.7bn in 1HFY24 impairments

BHP Group
3:27pm
February 15, 2024
BHP has flagged two large impairments ahead of its upcoming 1H24 result to be released on the 20th February. A US$2.5bn (post-tax) impairment against its Western Australia Nickel carrying-value (Nickel West and West Musgrave) and a US$3.2bn (post-tax) impairment for an increase in the Samarco Dam Failure provision. These impairments will be recognised as exceptional items in the 1H24 result and will not impact BHP’s underlying results, although could still add to BHP’s interim dividend considerations. We maintain our Hold rating with an unchanged Target Price of A$ps.

Growth at any cost?

South32
3:27pm
February 15, 2024
A largely in-line 1H24 result, while the surprise came in the form of updated numbers for the Hermosa Project with S32 reaching FID on the Taylor’s Deposit. 1H24 underlying EBITDA of US$708m (+5%/+2% vs MorgansF/consensus). Despite assuming a zinc price 28% above consensus, S32 still estimates an expected IRR on Hermosa of just 12%. Not leaving much margin for error. We expect S32 will be able to self-fund the Hermosa development out of operating cash flow and debt, although weighing on FCF until FY28. Hermosa looks difficult from a value perspective, but could help S32 gain earnings power. Further expansion through Clark/Peak/Flux could unlock better value. We maintain an Add rating, with a reduced valuation-based 12-month Target Price of A$4.00ps (was A$4.75ps).

Never one to stand still

MAAS Group
3:27pm
February 15, 2024
MGH delivered a good 1H24 result, beating VA consensus expectations and reiterating full year guidance for EBITDA of $190m-$210m. Furthermore, the business announced the acquisition of a further $80m of construction material assets in Victoria and additional industrial land purchases in NSW. So while these assets lay the foundation of future earnings growth, it has seen net debt remain broadly unchanged and gearing at 2.3x Net Debt to EBITDA (excluding leases). With MGH trading on an FY25 PER of 12.6x, the business offers more growth and a lower multiple than many of its peers, with the discount likely attributable to the continued contribution of acquisitions in driving EBITDA growth and the expectation that the business will remain geared at 2-3x EBITDA (excluding leases) over the near term. On this basis, we retain our Add rating, upgrading our target price to $4.35/sh (previously: $4.05/sh).

It gets better from here

Treasury Wine Estates
3:27pm
February 15, 2024
As we expected, TWE reported a weak 1H result, particularly from Treasury Americas (TA). Full year guidance for the base business was revised marginally however the DAOU acquisition remains on track. We have made minor revisions to our forecasts. With greater US Luxury supply, the addition of the DAOU acquisition and the potential removal of China’s tariffs, earnings growth should accelerate in FY25. Trading on a FY25 PE of 17.4x, TWE is trading at a material discount to its 5-year average of 25x and we maintain an Add rating. The key near term catalyst is China removing the tariffs on Australian wine imports.

1H24 earnings: Electric Touch

Beacon Lighting
3:27pm
February 15, 2024
An acceleration in the growth of Beacon Lighting’s (BLX) Trade business offset a reduction in Retail sales in 1H24, underpinning a record top line performance and causing it to beat our NPAT estimate by 6%. Despite the higher proportion of lower margin Trade sales in the group revenue mix, gross margins stepped up 140 bps as BLX secured better prices from its suppliers and benefitted from lower freight rates. We see these gains as largely sustainable. We expect LFLs to move up over the rest of FY24, supported by less demanding comps. Although inflation in operating costs is inescapable, we believe BLX can minimise the reduction in net income this year and return to growth in FY25. When Retail reverts to a cyclical upswing, the leverage to the bottom line will be meaningful. With its strong market position and compelling growth strategies, BLX is a stock to have in your portfolio.

Kmart Group does the heavy lifting

Wesfarmers
3:27pm
February 15, 2024
WES’s 1H24 result was above our forecasts and Visible Alpha consensus. Kmart Group was the key highlight with EBIT jumping 25% as customers become more value conscious with the business also benefitting from improved availability and productivity. For the first five weeks of 2H24, management said Kmart Group sales have remained strong, while sales growth in Bunnings was broadly in line with 1H24 and Officeworks sales were in line with the pcp. We increase FY24-26F group EBIT by between 1-2% with upgrades to Kmart Group earnings largely offset by reductions in the other divisions. Our target price increases to $62.30 (from $55.15) mainly due to a roll-forward of our model to FY25 forecasts. With a 12-month forecast TSR of 4%, we downgrade our rating to Hold (from Add). We continue to see WES as a core portfolio holding but think there will be opportunities for a better entry point in the near term.

News & Insights

The Your Wealth publication is our half yearly scrutiny into current affairs for wealth management. Our latest Issue 29 is out now.

The second half of 2025 will be an interesting time for everyone. Geopolitical uncertainty prevails. How will all of this impact the Australian investor and in particular, their wealth and retirement savings? Whether you are an accumulator, saving for short- and long-term goals, or a retiree, hoping for a comfortable retirement, the ability to manage this uncertainty will be key.

When we published the previous Your Wealth – First Half 2025, the Division 296 Bill (Div296) was also facing uncertainty. The Bill was eventually blocked in the Senate prior to the Federal Election. The Labor Party succeeded in winning so it’s Ground Hog Day for Div296. The Government doesn’t have the numbers in the Senate to pass the Bill without support from other parties. The Greens are the likely negotiating party but will undoubtably have their own agenda. Regardless, there is a high probability this legislation will be passed once Parliament resumes.

Our message to our clients is to wait until we know more details and to not act in haste.

In addition to our Feature Article which provides further insights on Div296, this edition also Spotlights the Aged Care changes due this year, with the start date pushed back to 1 November.

We hope readers enjoy this edition of Your Wealth.


Morgans clients receive exclusive insights such as access to our latest Your Wealth publication. Contact us today to begin your journey with Morgans.

      
Contact us
      
Read more
Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more